Assembly Biosciences, Inc. (NASDAQ: ASMB) reported Q1 EPS of ($1.66), $1.39 worse than the analyst estimate of ($0.27). Revenue for the quarter came in at $5.79 million.

For earnings history and earnings-related data on Assembly Biosciences, Inc. (ASMB) click here.